» Articles » PMID: 11148217

Fibroblast Growth Factor-binding Protein is a Novel Partner for Perlecan Protein Core

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Jan 20
PMID 11148217
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Perlecan, a widespread heparan sulfate proteoglycan, functions as a bioactive reservoir for growth factors by stabilizing them against misfolding or proteolysis. These factors, chiefly members of the fibroblast growth factor (FGF) gene family, are coupled to the N-terminal heparan sulfate chains, which augment high affinity binding and receptor activation. However, rather little is known about biological partners of the protein core. The major goal of this study was to identify novel proteins that interact with the protein core of perlecan. Using the yeast two-hybrid system and domain III of perlecan as bait, we screened approximately 0.5 10(6) cDNA clones from a keratinocyte library and identified a strongly interactive clone. This cDNA corresponded to FGF-binding protein (FGF-BP), a secreted protein previously shown to bind acidic and basic FGF and to modulate their activities. Using a panel of deletion mutants, FGF-BP binding was localized to the second EGF repeat of domain III, a region very close to the binding site for FGF7. FGF-BP could be coimmunoprecipitated with an antibody against perlecan and bound in solution to recombinant domain III-alkaline phosphatase fusion protein. Immunohistochemical analyses revealed colocalization of FGF-BP and perlecan in the pericellular stroma of various squamous cell carcinomas suggesting a potential in vivo interaction. Thus, FGF-BP should be considered a novel biological ligand for perlecan, an interaction that could influence cancer growth and tissue remodeling.

Citing Articles

Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.

Mongiat M, Pascal G, Poletto E, Williams D, Iozzo R Proteoglycan Res. 2024; 2(3).

PMID: 39184370 PMC: 11340296. DOI: 10.1002/pgr2.22.


Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D or eldecalcitol.

Shintani T, Higaki M, Rosli S, Okamoto T In Vitro Cell Dev Biol Anim. 2024; 60(6):583-589.

PMID: 38713345 PMC: 11286729. DOI: 10.1007/s11626-024-00913-3.


Global impact of proteoglycan science on human diseases.

Xie C, Schaefer L, Iozzo R iScience. 2023; 26(11):108095.

PMID: 37867945 PMC: 10589900. DOI: 10.1016/j.isci.2023.108095.


Conditional expression of endorepellin in the tumor vasculature attenuates breast cancer growth, angiogenesis and hyaluronan deposition.

Chen C, Kapoor A, Xie C, Moss A, Vadigepalli R, Ricard-Blum S Matrix Biol. 2023; 118:92-109.

PMID: 36907428 PMC: 10259220. DOI: 10.1016/j.matbio.2023.03.005.


Epithelial Basement Membrane Regeneration After PRK-Induced Epithelial-Stromal Injury in Rabbits: Fibrotic Versus Non-fibrotic Corneal Healing.

de Oliveira R, Sampaio L, Shiju T, Santhiago M, Wilson S J Refract Surg. 2022; 38(1):50-60.

PMID: 35020537 PMC: 8852807. DOI: 10.3928/1081597X-20211007-02.